January/February 2016 Top Social Media News

Jack Cush, MD

Mar 17, 2016 3:54 pm

In February 2016, RheumNow published 82 tweets about impactful news, research and teaching points that impact the rheumatology community. These feeds had a reach (impressions) of 80,800 with, 76 mentions, and over 2700 visits to learn on RheumNow.com. The average daily “tweet” from RheumNow is seen by 3000-8,000, with as many as 89,500 viewers for a single tweet. Our social media feeds are just one of several ways we deliver information to over 2500 rheumatologists and 2631 followers on Twitter. The following is a list of top tweets from January and February 2016; news items were selected based on the number of clicks, retweets and likes by the viewership.

CDC issues a Zika Virus update: reviews those at risk and characteristic manifestations: acute fever, maculopapular rash, arthralgia, conjunctivitis, fetal loss, and microcephaly associated with pregnancy. http://buff.ly/20nSiOz This was published on 1/25/16 and had a reach of 89,500 viewers.
JAMA Neurology publishes a population study showing that chronic use of proton pump inhibitors is associated with a higher risk of dementia. Unclear if this association is causal or casual. http://buff.ly/20Aoblb Published on 2/15/16 this post was viewed by 28,500.
French guideline published on infection prevention in SLE; overall everyone needs influenza pneumococcal vaccination; avoid live virus vaccines, but no consensus on prophylaxis for pneumocystis. http://buff.ly/20VVm2O Published on 2/25/16, this report was viewed by 15,400.
Posterior reversible encephalopathy syndrome (PRES) is a rare CNS manifestation in SLE. Risk is more common in younger patients and higher in those with hypertension, renal insufficiency, high disease activity, lymphopenia, and interestingly, hyperlipidemia. http://buff.ly/1Qn2iUZ This report was posted on 2/29/16 and was seen by 15,400.
A blog on Ten Ways that RA could’ve killed famous Eagle - Glenn Frey. A major musical loss a reminder how behind we are in our management of RA. http://buff.ly/1Jrbxm4 Published on 1/23/16, it was seen by 14,700.
The ocular manifestations of lupus are reviewed in BMJ. Microangiopathy is the most common finding, but optic neuritis is not common or associated with CNS lupus. http://buff.ly/1PvJ9hA This was published on 1/2/16 and viewed by 14600.
FDA arthritis advisory committee reviewed a new biosimilar and voted 21-3 in favor of approving Celltrions’ CT-P13 (to be named Inflectra), a biosimilar of infliximab. http://buff.ly/1R1Cuwk This was posted on the day of the meeting, 2/9/16, and was viewed by 14,500.
Nurses health study (>77000) review shows that chronic (4 – 10 yrs.) use of non-aspirin NSAIDs was associated with a significantly higher (34%) increased future risk of renal cell carcinoma. http://buff.ly/1OsevDr This was published on 1/14/16 and seen by 13100.
Cohort review of IBD patients on Infliximab shows that drug induced skin manifestations are not uncommon (23%) and includes eczema and psoriasis like lesions - 41% these were exacerbations of underlying skin conditions. http://buff.ly/1Kk5K27 Published on 2/16/16, the report was seen by 12000.
Metanalyses shows use of the influenza vaccine in lupus is safe; does not induce lupus flares and is moderately effective; although seroconversion rates are lower in lupus patients. http://buff.ly/1Q1MGEU This was posted on 2/24/16 and seen by 8900 viewers.